These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15362666)

  • 1. CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users.
    Nguyen L; Li M; Chaowanachan T; Hu DJ; Vanichseni S; Mock PA; van Griensven F; Martin M; Sangkum U; Choopanya K; Tappero JW; Lal RB; Yang C
    AIDS; 2004 Jun; 18(9):1327-33. PubMed ID: 15362666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression.
    Li M; Song R; Masciotra S; Soriano V; Spira TJ; Lal RB; Yang C
    AIDS Res Hum Retroviruses; 2005 Feb; 21(2):111-5. PubMed ID: 15725749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand.
    Yang C; Li M; Limpakarnjanarat K; Young NL; Hodge T; Butera ST; McNicholl JM; Mastro TD; Lal RB
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):661-5. PubMed ID: 13678468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
    Schinkel J; Langendam MW; Coutinho RA; Krol A; Brouwer M; Schuitemaker H
    J Infect Dis; 1999 Apr; 179(4):825-31. PubMed ID: 10068577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.
    Picton AC; Paximadis M; Tiemessen CT
    Immunogenetics; 2012 Nov; 64(11):795-806. PubMed ID: 22893032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.
    Wang FS; Hong WG; Cao Y; Liu MX; Jin L; Hu LP; Wang Z; Feng TJ; Hou J; Zhang B; Shi M; Xu DP; Lei ZY; Wang B; Liu ZD; Ye JJ; Peng L; Qiu Y; Winkler C
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):124-30. PubMed ID: 12571520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
    Ioannidis JP; Rosenberg PS; Goedert JJ; Ashton LJ; Benfield TL; Buchbinder SP; Coutinho RA; Eugen-Olsen J; Gallart T; Katzenstein TL; Kostrikis LG; Kuipers H; Louie LG; Mallal SA; Margolick JB; Martinez OP; Meyer L; Michael NL; Operskalski E; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Stewart GJ; Theodorou ID; Ullum H; Vicenzi E; Vlahov D; Wilkinson D; Workman C; Zagury JF; O'Brien TR;
    Ann Intern Med; 2001 Nov; 135(9):782-95. PubMed ID: 11694103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of human chemokine (C-X3-C) receptor 1 (CX3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression.
    Li C; Lu SC; Hsieh PS; Huang YH; Huang HI; Ying TH; Shieh B
    Int J Immunogenet; 2005 Apr; 32(2):99-106. PubMed ID: 15787642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
    Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
    BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
    Eugen-Olsen J; Iversen AK; Benfield TL; Koppelhus U; Garred P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):110-6. PubMed ID: 9637575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
    Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
    Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.
    Malhotra R; Hu L; Song W; Brill I; Mulenga J; Allen S; Hunter E; Shrestha S; Tang J; Kaslow RA
    Retrovirology; 2011 Mar; 8():22. PubMed ID: 21429204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
    Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
    AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
    Easterbrook PJ; Rostron T; Ives N; Troop M; Gazzard BG; Rowland-Jones SL
    J Infect Dis; 1999 Oct; 180(4):1096-105. PubMed ID: 10479136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic associations and epistatic effects of the CCR5 promoter and CCR2-V64I polymorphisms on susceptibility to HIV-1 infection in a Northern Han Chinese population.
    Lu J; Sheng A; Wang Y; Zhang L; Wu J; Song M; He Y; Yu X; Zhao F; Liu Y; Shao S; Lan J; Wu H; Wang W
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1369-75. PubMed ID: 23057571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Martin MP; Dean M; Smith MW; Winkler C; Gerrard B; Michael NL; Lee B; Doms RW; Margolick J; Buchbinder S; Goedert JJ; O'Brien TR; Hilgartner MW; Vlahov D; O'Brien SJ; Carrington M
    Science; 1998 Dec; 282(5395):1907-11. PubMed ID: 9836644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.